Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,950.00
(
0.90%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,340.74
(
0.19%
)
News Focus
News Focus
Post# of 824026
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

space~farm

Send PM Follow Ignore
Followers 0
Posts 292
Boards Moderated 0
Alias Born 05/04/2022

space~farm

Re: seekinganswers post# 787392

Tuesday, 09/09/2025 10:01:37 PM

Tuesday, September 09, 2025 10:01:37 PM

Post# of 824026
I don’t get why posters can’t comprehend this and call it FUD. This is just pharma101. If the rebuttal is their current manufacturing structure being a limitation, well that is still a failure on behalf of NWBO.

However I don’t think the trial is a failure. A little messy sure but that is just a product of the knowledge at the time of trial design. The lack of filing is a failure on management, having everything outsourced, and not building a strong internal team IMO.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News